carbamates has been researched along with Colitis in 6 studies
Colitis: Inflammation of the COLON section of the large intestine (INTESTINE, LARGE), usually with symptoms such as DIARRHEA (often with blood and mucus), ABDOMINAL PAIN, and FEVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the effect of givinostat treatment in acetic acid-induced ulcerative colitis model in rats." | 8.12 | Histone deacetylase inhibitor givinostat has ameliorative effect in the colitis model. ( Dibekoğlu, C; Erbaş, O, 2022) |
| "To investigate the effect of givinostat treatment in acetic acid-induced ulcerative colitis model in rats." | 4.12 | Histone deacetylase inhibitor givinostat has ameliorative effect in the colitis model. ( Dibekoğlu, C; Erbaş, O, 2022) |
| "Givinostat treatment mediated an accelerated wound closure in scratch assays." | 1.51 | HDAC inhibitors promote intestinal epithelial regeneration via autocrine TGFβ1 signalling in inflammation. ( Friedrich, M; Gerbeth, L; Gerling, M; Glauben, R; Keye, J; Rosenthal, R; Schmidt, F; Siegmund, B; Steiger, K; Weichert, W; Weidinger, C; Wu, H, 2019) |
| "Genomic DNA from 202 patients with Crohn's disease (CD) and 206 healthy controls was analyzed for the C385A polymorphism in the FAAH gene to address a possible role in humans." | 1.35 | Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors. ( Brand, S; Buckley, NE; Emmerdinger, D; Göke, B; Keenan, CM; Lutz, B; Massa, F; Patel, KD; Sharkey, KA; Sibaev, A; Storr, MA; Yüce, B; Zhang, H, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dibekoğlu, C | 1 |
| Erbaş, O | 1 |
| Gelsomino, F | 1 |
| Di Federico, A | 1 |
| Tardio, ML | 1 |
| Grilli, G | 1 |
| D'Errico, A | 1 |
| Ardizzoni, A | 1 |
| Salvagni, S | 1 |
| Friedrich, M | 1 |
| Gerbeth, L | 1 |
| Gerling, M | 1 |
| Rosenthal, R | 1 |
| Steiger, K | 1 |
| Weidinger, C | 1 |
| Keye, J | 1 |
| Wu, H | 1 |
| Schmidt, F | 1 |
| Weichert, W | 1 |
| Siegmund, B | 1 |
| Glauben, R | 1 |
| Steimle, A | 1 |
| Gronbach, K | 1 |
| Beifuss, B | 1 |
| Schäfer, A | 1 |
| Harmening, R | 1 |
| Bender, A | 1 |
| Maerz, JK | 1 |
| Lange, A | 1 |
| Michaelis, L | 1 |
| Maurer, A | 1 |
| Menz, S | 1 |
| McCoy, K | 1 |
| Autenrieth, IB | 1 |
| Kalbacher, H | 1 |
| Frick, JS | 1 |
| Storr, MA | 1 |
| Keenan, CM | 1 |
| Emmerdinger, D | 1 |
| Zhang, H | 1 |
| Yüce, B | 1 |
| Sibaev, A | 1 |
| Massa, F | 1 |
| Buckley, NE | 1 |
| Lutz, B | 1 |
| Göke, B | 1 |
| Brand, S | 1 |
| Patel, KD | 1 |
| Sharkey, KA | 1 |
| Troutt, HF | 1 |
| Hooper, BE | 1 |
| Harrington, R | 1 |
6 other studies available for carbamates and Colitis
| Article | Year |
|---|---|
Histone deacetylase inhibitor givinostat has ameliorative effect in the colitis model.
Topics: Acetic Acid; Animals; Carbamates; Colitis; Colitis, Ulcerative; Colon; Histone Deacetylase Inhibitor | 2022 |
Drug-induced colitis on BRAF and MEK inhibitors for BRAF V600E-mutated non-small cell lung cancer: a case report.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Carbama | 2022 |
HDAC inhibitors promote intestinal epithelial regeneration via autocrine TGFβ1 signalling in inflammation.
Topics: Animals; Autocrine Communication; Carbamates; Cells, Cultured; Colitis; Disease Models, Animal; Elec | 2019 |
Symbiotic gut commensal bacteria act as host cathepsin S activity regulators.
Topics: Animals; Bacteria; Bacteroides; Bacteroides Infections; Benzopyrans; Blotting, Western; Bone Marrow | 2016 |
Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors.
Topics: Amidohydrolases; Animals; Arachidonic Acids; Benzamides; Cannabinoid Receptor Modulators; Carbamates | 2008 |
Effect of carbadox in experimentally induced salmonellosis of swine.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Body Temperature; Body Weight; Carbamates; Col | 1974 |